- Home
- MRUS vs SNEX Comparison
MRUS vs SNEX Comparison
Compare MRUS & SNEX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MRUS
- SNEX
- Stock Information
- Founded
- MRUS 2003
- SNEX 1924
- Country
- MRUS Netherlands
- SNEX United States
- Employees
- MRUS 260
- SNEX N/A
- Industry
- MRUS Biotechnology: Pharmaceutical Preparations
- SNEX Investment Bankers/Brokers/Service
- Sector
- MRUS Health Care
- SNEX Finance
- Exchange
- MRUS Nasdaq
- SNEX Nasdaq
- Market Cap
- MRUS 4.1B
- SNEX 4.1B
- IPO Year
- MRUS 2016
- SNEX 1994
- Fundamental
- Price
- MRUS $53.11
- SNEX $84.67
- Analyst Decision
- MRUS Strong Buy
- SNEX Buy
- Analyst Count
- MRUS 12
- SNEX 1
- Target Price
- MRUS $87.92
- SNEX N/A
- AVG Volume (30 Days)
- MRUS 2.0M
- SNEX 261.4K
- Earning Date
- MRUS 07-31-2025
- SNEX 08-05-2025
- Dividend Yield
- MRUS N/A
- SNEX N/A
- EPS Growth
- MRUS N/A
- SNEX 17.88
- EPS
- MRUS N/A
- SNEX 5.90
- Revenue
- MRUS $54,732,000.00
- SNEX $121,723,000,000.00
- Revenue This Year
- MRUS $75.57
- SNEX N/A
- Revenue Next Year
- MRUS $31.84
- SNEX $0.21
- P/E Ratio
- MRUS N/A
- SNEX $14.52
- Revenue Growth
- MRUS 42.77
- SNEX 68.26
- 52 Week Low
- MRUS $33.19
- SNEX $47.33
- 52 Week High
- MRUS $62.98
- SNEX $97.17
- Technical
- Relative Strength Index (RSI)
- MRUS 53.18
- SNEX 47.71
- Support Level
- MRUS $52.41
- SNEX $83.96
- Resistance Level
- MRUS $54.59
- SNEX $87.46
- Average True Range (ATR)
- MRUS 2.15
- SNEX 2.22
- MACD
- MRUS -0.77
- SNEX -0.04
- Stochastic Oscillator
- MRUS 7.62
- SNEX 50.76
About MRUS Merus N.V.
Merus NV is a clinical-stage immuno-oncology company. It develops bispecific antibody therapeutics. The company is developing full-length human multispecific antibody therapeutics, referred to as Biclonics. Merus has only one reportable segment comprising the discovery and development of bispecific therapeutics. Some of its products in the pipeline include MCLA-128; MCLA-117; MCLA-158 and others.
About SNEX StoneX Group Inc.
StoneX Group Inc is a Global brokerage and financial services firm. Its service offerings are execution, OTC / Market-Making, advisory services, Global payment solutions, market intelligence, Physical Trading and clearing services. The firm operates in four segments: Commercial, Institutional, Self-Directed/Retail, and Payments. Its customers include governmental and nongovernmental organizations, commercial banks, brokers, institutional investors, and investment banks. The company operates in the United States, South America, Europe, the Middle East and Asia, and other countries, out of which the majority of revenue is generated from the Middle East and Asia Region.